BioWorld Asia

July 19, 2006

View Archived Issues

Actelion, Roche Sign $630M Autoimmunity Product Deal

Shrugging off recent disappointments in the clinic, Actelion AG signed what is likely to be one of the landmark licensing deals in European biotechnology in 2006. (BioWorld International) Read More

DeCode Stock Sale To Raise $30M For Multidrug Pipeline

Read More

Motility Control Proteins Might Play Part In Pancreatic Cancer

Read More

Crucell Shares Fall After Aerugen Program Ended

Read More

ProStrakan Secures Deal, Raises £11M In Placement

Read More

Nasdaq In Lead, But Potential LSE Merger Raises Questions

Read More

Cellectis, Lexicon Genetics Exchange Rights To Patents

Read More

Devices In Past, Medisys Now Complete As Investing Firm

Read More

Advanced Therapies Under Scrutiny At EU Parliament

Read More

Astion Brings In DKK50M For Dermatology Pipeline

Read More

Other News To Note

Read More